Skip to content
healthcare.dev

DAPAGLIFLOZIN AND SAXAGLIPTIN

NDC 72205-438, DAPAGLIFLOZIN AND SAXAGLIPTIN, tablet, film coated, from Novadoz Pharmaceuticals LLC.

Product NDC
72205-438
Status
Listed
Labeler
Novadoz Pharmaceuticals LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211533
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72205-438 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN10 mg/1
  • SAXAGLIPTIN HYDROCHLORIDE DIHYDRATE5 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
72205-438-017220504380130 TABLET, FILM COATED in 1 BOTTLE (72205-438-01)
72205-438-027220504380290 TABLET, FILM COATED in 1 BOTTLE (72205-438-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1cfa51fd-8406-404c-b2a8-0fc1068675fb

Use it

Look up 72205-438 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72205-438 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72205-438. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.